Oral fluids (saliva, mouthrinse, gingival crevicular fluid [GCF], and peri-implant sulcular fluid [PISF]) provide a matrix for periodontitis and dental peri-implant biomarker diagnostics as recently studied by Schmalz et al. (2019) . In periodontitis and peri-implantitis, elevated levels of neutrophil collagenase or collagenase-2, especially in active/ activated form, reflect, predict, and monitor the diagnosis, course, and treatment of these diseases. Oral fluid active matrix metalloproteinase-8 (aMMP-8)/neutrophil collagenase is a potential point-of-care (PoC)/chairside biomarker for these diseases, and commercially available aMMP-8 PoC tests have been developed and are in use. GCF and PISF have often been sampled at individual sites using filter papers and/or micropipettes (Rathnayake et al. 2017) , but there is an alternative way to sample GCF: a wash using a mouthrinse technique (Drouin et al. 1988; Gangbar et al. 1990 ). This simpler technique utilizing mouthrinse has been developed to collect GCF from periodontitis patients (Gangbar et al. 1990; Nwhator et al. 2014; Heikkinen et al. 2016; Räisänen et al. 2019a ). The aim of this note is to provide more accurate assessment of the efficiency of mouthrinse vs. salivary aMMP-8 analysis in discrimination of periodontal health and disease. Fig. 1 illustrates the ability of aMMP-8 PoC mouthrinse test compared to aMMP-8 IFMA measured from saliva, and it clearly shows how saliva is inferior to mouthrinse in aMMP-8 measurements related to identifying periodontal health and disease. There is a significant association between the aMMP-8 PoC mouthrinse test result and aMMP-8 IFMA levels in saliva in this sample of adolescents, as has been shown recently by Räisänen et al. (2019b) . However, if patient's periodontal health is considered, the distinction of salivary aMMP-8 IFMA measurements is far from perfect between a positive and negative test result. aMMP-8 IFMA concentrations vary between similar maximum and minimum levels independent of the patient's number of sites (0 or 1, and 2 or more) with ≥4 mm periodontal pockets. On the contrary, the aMMP-8 mouthrinse test is very sensitive for at least 2 sites with . It is instructive that the sensitivity regarding 2 sites with periodontal pockets of ≥4 mm had been reported in 2014 long before it was mentioned in the latest classification (Tonetti et al. 2018) . As indicated in Fig. 1, aMMP-8 PoC mouthrinse test functions much better and more precisely, which suggests that mouthrinse aMMP-8 measurements are the optimal way of analyzing patient's risk for active periodontal tissue destruction and progression of periodontal disease. Furthermore, the use of mouthrinse aMMP-8 to measure active collagenases avoids the interference by tissue inhibitors of metalloproteinase (TIMPs) when saliva is used (Drouin et al. 1988; Gangbar et al. 1990 ).
In accordance with the original findings of Drouin et al. (1988) and Gangbar et al. (1990) , as well the recent studies using the aMMP-8 chairside PoC tests (Nwhator et al. 2014; Izadi Borujeni et al. 2015; Heikkinen et al. 2016; Johnson et al. 2016; Sorsa et al. 2016; Heikkinen et al. 2017; Lorenz et al. 2017; Alassiri et al. 2018; Leppilahti et al. 2018; Räisänen et al. 2018; Schmidt et al. 2018; Schmalz et al. 2019; Räisänen et al. 2019a ), repeatedly and strongly indicate that aMMP-8 or active neutrophil collagenase present in mouthrinse is derived from GCF and neutrophils. Regarding saliva, there are multiple other potential sources for aMMP-8 in addition to neutrophils (Rathnayake et al., 2017) . Overall, mouthrinse provides calibration and standardization of the GCF and its aMMP-8 biomarker to be quantitatively analyzed (Nwhator et al. 2014; Izadi Borujeni et al. 2015; Heikkinen et al. 2016; Johnson et al. 2016; Sorsa et al. 2016; Heikkinen et al. 2017; Lorenz et al. 2017; Sorsa et al. 2017; Alassiri et al. 2018; Leppilahti et al. 2018; Räisänen et al. 2018; Schmidt et al. 2018; Schmalz et al. 2019; Räisänen et al. 2019a ). Additional studies have further shown that aMMP-8, but not total MMP-8, can predict and differentiate between "active" and "inactive" periodontal pockets (Lee et al. 1995; Mancini et al. 1999; Romanelli et al. 1999; Kiili et al. 2002; Sorsa et al. 2006) , and standard-of-care treatment (i.e., scaling and root planing) reduces aMMP-8 levels in oral fluid (GCF and mouthrinse) and, at the same time, ceases the clinical progression of the disease (Mäntylä et al. 2003; Leppilahti et al. 2014; Leppilahti et al. 2015; Alassiri et al. 2018 ). Elevation of aMMP-8 (N20 ng/mL) by 2 or even 1 active deep site is required for the chairside PoC test to be positive to indicate increased risk for periodontitis and/or its development and progression, thus reflecting the high sensitivity of commercially available aMMP-8 PoC mouthrinse test (Nwhator et al. 2014; Heikkinen et al. 2016; Räisänen et al. 2019a ). This was also originally observed for active collagenase activity by Gangbar et al. (1990) . Salivary analysis of periodontitis biomarkers is on the other hand less exact and potentially erroneous (Fig. 1) . Thus, the aMMP-8 oral fluid test is a mouthrinse-not salivary -test addressing GCF/PISF aMMP-8 in periodontal disease. 
